Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Accenture (ACN) rated new Market Perform at BMO Capital Markets. $70 price target. Best positioned firm in sector, but held back by valuation.
Analog Devices (ADI) downgraded at Sterne from Buy to Neutral. Company is seeing weaker industrial orders and is leveraged to lower consumer spending.Amerigroup (AGP) downgraded at BofA/Merrill to Underperform from Buy. Company is facing higher costs. $46 price target. Allstate (ALL) downgraded at Goldman from Neutral to Sell. Company has less exposure to rising property catastrophe pricing. AMR (AMR) downgraded at JPMorgan from Overweight to Neutral. Revised loss projections no longer support sufficient upside potential. Brown-Forman (BF/B) rated new Underweight at Barclays. Company is facing increased competition from Jim Beam. BHP Billiton (BLT) downgraded at Credit Suisse from Outperform to Neutral. $47 price target. Incorporating the Petrohawk acquisition into model. Choice Hotels (CHH) upgraded at Credit Suisse from Underperform to Neutral. $30 price target. Valuation call, as stock price has fallen dramatically. Cognizant Technology (CTSH) rated new Outperform at BMO Capital Markets. $86 price target. Company can support attractive growth for a few years. Corporate Exec. Board (EXBD) upgraded at Barclays from Neutral to Overweight. $45 price target. Stock appears oversold, as growth should accelerate in the second half of the year. Corporate Exec. Board upgraded at Deutsche from Hold to Buy. $45 price target. Company is cutting costs, but can still deliver double-digit bookings growth. Fiserv (FISV) upgraded at Baird from Neutral to Outperform. Valuation call, based on a $70 price target. Fortune Brands (FO) rated new Overweight at Barclays Capital. Jim Beam should help drive near-term growth. KiOR (KIOR) rated new Buy at Citigroup. $21 price target. Potential to be first successful biofuel company. KiOR rated new Buy at UBS. $28 price target. Strong support from local and US government programs. Marriott International (MAR) downgraded at BofA/Merrill from Buy to Neutral. $34 price target. Company is leveraged to lower GDP growth. Marathon Oil (MRO) downgraded at Credit Suisse from Outperform to Neutral. $36 price target. Unplanned downtime and tax rates also rising versus forecasts.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV